Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'.
复制标题
DOI:
10.1038/nature10975
复制
发表时间:
2012-03-25
期刊:
影响因子:
64.8
通讯作者:
Garcia, K. Christopher
中科院分区:
文献类型:
--
作者:
Levin, Aron M.;Bates, Darren L.;Ring, Aaron M.;Krieg, Carsten;Lin, Jack T.;Su, Leon;Moraga, Ignacio;Raeber, Miro E.;Bowman, Gregory R.;Novick, Paul;Pande, Vijay S.;Fathman, C. Garrison;Boyman, Onur;Garcia, K. Christopher
The immunostimulatory cytokine interleukin-2 (IL-2) is a growth factor for a wide range of leukocytes, including T cells and natural killer (NK) cells. Considerable effort has been invested using IL-2 as a therapeutic agent for a variety of immune disorders ranging from AIDS to cancer. However, adverse effects have limited its use in the clinic. On activated T cells, IL-2 signals through a quaternary “high affinity” receptor complex consisting of IL-2, IL-2Rα (termed CD25), IL-2Rβ, and γc. Naïve T cells express only a low density of IL-2Rβ and γc, and are therefore relatively insensitive to IL-2, but acquire sensitivity after CD25 expression, which captures the cytokine and presents it to IL-2Rβ andγc. Here, using in vitro evolution, we eliminated IL-2’s functional requirement for CD25 expression by engineering an IL-2 “superkine” (termed super-2) with increased binding affinity for IL-2Rβ. Crystal structures of super-2 in free and receptor-bound forms showed that the evolved mutations are principally in the core of the cytokine, and molecular dynamics simulations indicated that the evolved mutations stabilized IL-2, including a flexible helix in the IL-2Rβ binding site, into an optimized receptor-binding conformation resembling that when bound to CD25. The evolved mutations in super-2 recapitulated the functional role of CD25 by eliciting potent phosphorylation of STAT5 and vigorous proliferation T cells irrespective of CD25 expression. Compared to IL-2, super-2 induced superior expansion of cytotoxic T cells, leading to improved anti-tumor responses in vivo, and elicited proportionally less expansion of T regulatory cells and reduced pulmonary edema. Collectively, we show that in vitro evolution has mimicked the functional role of CD25 in enhancing IL-2 potency and regulating target cell specificity, which has implications for immunotherapy.
登录
查看更多内容
影响因子:
44.1
作者:
通讯作者:
--
影响因子:
5.5
作者:
Hess, Berk;Kutzner, Carsten;Lindahl, Erik
通讯作者:
Lindahl, Erik
DOI:
10.1107/s0907444904019158
发表时间:
2004-12-01
影响因子:
2.2
作者:
Emsley, P;Cowtan, K
通讯作者:
Cowtan, K
DOI:
10.1073/pnas.0909384107
发表时间:
2010-02-02
影响因子:
11.1
作者:
Letourneau, Sven;van Leeuwen, Ester M. M.;Boyman, Onur
通讯作者:
Boyman, Onur
影响因子:
5.5
作者:
Hess, Berk
通讯作者:
Hess, Berk